EN
HI
Summary
As of 1 Sep, 2026, Cipla stock price is ₹1412. During the trading session, the stock has moved between an intraday low of ₹1406.50 and an intraday high of ₹1425.70. Over the last 52 weeks, Cipla has traded between ₹1165.70 and ₹1673.00.
The stock has recorded a trading volume of 2,75,022 shares, with a market capitalization of ₹807845316. Its Average Traded Price (ATP) is ₹1414.11, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1412.00.
Cipla has an upper circuit limit of ₹1550.10 and a lower circuit limit of ₹1268.30. The total value traded stands at ₹38.89 CR, and the delivery percentage for the day is 73.1%.
The stock is currently traded with a market lot size of 1. Cipla also offers a dividend yield of 0.92%.
Cipla share price chart
Cipla Share Key Metrics
Volume
2.75 L
Market Cap
113841.56 CR
LTQ@LTP
1@1412.00
ATP
1414.11
Var Margin
12.5 %
Circuit Range
1268.3-1550.1
Delivery %
73.1 %
Value
38.89 CR
ASM/GSM
No
Market Lot
1
Cipla Fundamentals
P/E Ratio
33.94
P/B Ratio
3.25
Div. Yield
0.92
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Cipla Resistance and Support
Pivot 1414.83
Resistance
First Resistance
1420.46
Second Resistance
1431.73
Third Resistance
1437.36
Support
First Support
1403.56
Second Support
1397.93
Third Support
1386.66
Cipla Futures & Options
Cipla Option Chain
View Price, OI, Greeks & More...
29SEP26
1420.00
-5.80 (0.41%)
27OCT26
1427.20
-5.40 (0.38%)
23NOV26
1430.70
-12.60 (0.87%)
CIPLA|29SEP26 CE 1410.00
32.90
-3.55 (-9.74%)
CIPLA|29SEP26 PE 1420.00
27.6
2.4 (9.52%)
Cipla Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 01 2026 | 1420.9 | 1412 | 0.20% | 1425.7 | 1406.5 |
| Mon Aug 31 2026 | 1418 | 1409.19 | -1.01% | 1426.09 | 1409.19 |
| Fri Aug 28 2026 | 1420 | 1423.5 | 0.25% | 1423.9 | 1409.09 |
Cipla Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-13 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
Cipla News
Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cipla and SBP Group announced an exclusive licensing agreement for Rolditamig Deuderuxtecan (TQB2102), a HER2 bispecific ADC. The agreement grants Cipla rights to develop and commercialize the drug in India, South Africa, and five other emerging markets, aiming to accelerate patient access.
Aug 31 2026 15:42:53
Cipla Ltd - 500087 - Update On USFDA Inspection At Invagen Manufacturing Facility In Central Islip, Long Island, NY, USA
Cipla's wholly-owned subsidiary, InvaGen Pharmaceuticals, received a Voluntary Action Indicated (VAI) classification from the USFDA for its Unit 3 manufacturing facility in Central Islip, Long Island, NY. This classification indicates that while objectionable conditions were found during the July 2026 inspection, no regulatory action is currently warranted.
Aug 28 2026 21:17:08
Read More
Cipla Management
| Name | Position |
|---|---|
| Y K Hamied | Chairman |
| Kamil Hamied | Non Independent & Non Executive Director |
Cipla Similar Stocks
Sun Pharmaceutical Industries Ltd.
1930.10
-54.70 (2.76%)
Divi's Laboratories Ltd.
9172.00
-295.00 (3.12%)
Torrent Pharmaceuticals Ltd.
4957.50
-108.50 (2.14%)
Apollo Hospitals Enterprise Ltd.
8771.50
-127.00 (1.43%)
Zydus Lifesciences Ltd.
1173.10
11.80 (1.02%)
Lenskart Solutions Ltd.
662.00
-0.40 (0.06%)
Laurus Labs Ltd.
1848.10
-66.90 (3.49%)
Manipal Health Enterprises Ltd.
753.75
-9.05 (1.19%)
Lupin Ltd.
2151.50
-36.90 (1.69%)
Mankind Pharma Ltd.
2356.00
-63.20 (2.61%)
Cipla FAQs
The Buying Price of Cipla share is 1412 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cipla stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cipla, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cipla shares is 33.94. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cipla shares is 3.25. Useful to assess the stock's value relative to its book value.
To assess Cipla’s valuation compare Sector P/E, P/B which are 41.23 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cipla is 113841.56 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cipla share price is 1673.00 & 1165.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cipla belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
